Virginia Bove

Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study

Camila Peña, Eloísa Riva, Natalia Schütz et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 28 citations · Full text

Medicine, Hematology, Oncology +14

Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study

Eloísa Riva, Patricio Duarte, Bryan Valcárcel et al. · JCO Global Oncology · 2022 · 23 citations · Full text

Medicine, Internal Medicine, Oncology +12

Significant differences in access to tests and treatments for multiple myeloma between public and private systems in Latin America. Results of a Latin American survey. GELAMM (Grupo de Estudio Latino Americano de Mieloma Múltiple)

Eloísa Riva, Natalia Schütz, Camila Peña et al. · Annals of Hematology · 2020 · 19 citations

Medicine, Hematology, Epidemiologic Methods +7

Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma

Virginia Bove, David Garrido, Eloísa Riva · Hematology Transfusion and Cell Therapy · 2020 · 12 citations · Full text

Medicine, Geriatric Medicine, Hematology +13

Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America

Humberto Martínez‐Cordero, Camila Peña, Natalia Schütz et al. · JCO Global Oncology · 2023 · 11 citations · Full text

Medicine, Hematology, Internal Medicine +13